in Addition to Oxford University on a vaccine against the new type of coronavirus in Britain also works to king’s College London. Companies chose a different approach to vaccine development. In Oxford decided to create it on the basis of “harmless virus chimpanzee”, the so-called adenovirus. The idea is to modify it so that it has begun to make similar to SARS-CoV-2 surface of its shell, which the latter uses to human infection. As planned by the specialists, this will allow the human immune system makes it easier to identify COVID-19 and more effectively to deal with it.
the Team from the College of London is working to create a RNA-vaccine, which is “to give genetic a command to the cells of the human muscles” to produce a specific for SARS-CoV-2 protein. By the way, this group, the government allocated slightly more money to 22.5 million pounds (2.1 billion rubles).
At the University of Oxford claim that their vaccine may undergo initial testing by September of this year. Then you can start more widespread testing. While the University said that the British Agency that regulates the testing of new medicines, “went to meet the developers,” it is usually in obtaining permission for vaccines can take up to 18 months. This was confirmed by Minister Hancock. “The team (Oxford) accelerated the testing process, working closely with the regulatory body. As a result, I can announce that the vaccine from the Oxford project will begin human trials this Thursday,” said Hancock.
the Minister came amid the announcement of the new figures of the epidemic in the UK. Just last night the country died 823 persons, the total number of deaths amounted to 17337 people. Since the beginning of the epidemic was conducted 397670 tests for coronavirus, of which 129044 thousand tested positive.
